WuXi AppTec Co., Ltd. (2359.HK) is in Healthcare, Diagnostics & Research, based in China, listed on HKSE. Market cap 631.26B HKD. 52-week range 96.70 to 219.20 HKD. Trailing P/E 25.2. Data as of 2026-10-09.
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial ...